[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370751-105":59,"doc-detail-370751-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bioinformatic-analysis-and-retrospective-clinical-study-identifying-dnajb4-as-a-pan-cancer-biomarker-with-a-highlight-on-kidney-cancer","Bioinformatic analysis and retrospective clinical study identifying DNAJB4 as a pan-cancer biomarker with a highlight on kidney cancer","","DNAJB4 is examined as a tumor-suppressive factor and proteostasis-related gene across cancers. A comprehensive pan-cancer analysis evaluates DNAJB4 expression and clinical relevance using ceRNA networks, protein-protein interactions, tumor purity, genomic profiling, immune microenvironment characterization, and drug sensitivity, with pathway discovery via gene set enrichment analysis. DNAJB4 levels are lower in tumors than normals and link to outcomes, genomic alterations, immune features, and therapy response; kidney neoplasm validation uses immunohistochemistry in 370 patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bioinformatic-analysis-and-retrospective-clinical-study-identifying-dnajb4-as-a-pan-cancer-biomarker-with-a-highlight-on-kidney-cancer/370751/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bioinformatic-analysis-and-retrospective-clinical-study-identifying-dnajb4-as-a-pan-cancer-biomarker-with-a-highlight-on-kidney-cancer/370751.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study on DNAJB4?","Question",{"text":112,"@type":113},"To perform an extensive pan-cancer analysis of DNAJB4 expression and determine its clinical value, with additional emphasis on kidney neoplasm using immunohistochemistry.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which analytical components were used to assess DNAJB4 across cancers?",{"text":117,"@type":113},"The study integrates ceRNA analysis, protein-protein interaction networks, tumor purity estimation, genomic profiling, immune microenvironment evaluation, drug sensitivity assessment, and gene set enrichment analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about DNAJB4 expression in tumors versus normal tissues?",{"text":121,"@type":113},"DNAJB4 expression is significantly lower in tumor tissues than in normal tissues across the pan-cancer analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370751,1790219554,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Clinical and Experimental Medicine (2025) 25:260 [https://doi.org/10.1007/s10238-025-01806-9](https://doi.org/10.1007/s10238-025-01806-9)  \nBioinformatic analysis and retrospective clinical study identifying DNAJB4 as a pan‑cancer biomarker with a highlight on kidney cancer  \nChuanmin Chu1,2 · Bingnan Lu3 · Wenjia Fu3 · Muchen Li3 · Keqin Dong3 · Donghao Lyu3 · Yuntao Yao3 · Yuanan Li3 · Yifan Liu3 · Xiuwu Pan3 · Ming Chen1  \nReceived: 28 May 2025 / Accepted: 3 July 2025 / Published online: 22 July 2025 © The Author(s) 2025  \nAbstract  \nDNAJB4 plays a crucial role in tumor suppression and proteostasis across various cancers. However, a comprehensive pancancer analysis of DNAJB4 remains lacking. We performed an extensive pan-cancer analysis to assess DNAJB4 expression and its clinical value. Analyses included competing endogenous RNA, protein–protein interaction networks, tumor purity, genomic profiling, immune microenvironment evaluation, and drug sensitivity. Gene set enrichment analysis was used to identify key pathways associated with DNAJB4. Additionally, DNAJB4 expression was evaluated in a cohort of 370 kidney neoplasm patients using immunohistochemistry to explore its clinical significance. DNAJB4 expression was significantly lower in tumor tissues compared to normal tissues in pan-cancer analysis. Reduced expression of DNAJB4 correlated with clinical outcomes, tumor purity, genomic alterations, immune microenvironment features, and drug sensitivity. In kidney neoplasm patients, DNAJB4 expression was significantly lower in tumor tissues (P value \u003C 0.001) and was associated with poor prognosis, including progression-free survival (P value \u003C 0.01) and overall survival (P value \u003C 0.05) . Higher DNAJB4 levels were linked to advanced tumor stages (P value \u003C 0.001 for T2b–T4, P value \u003C 0.01 for stages 3–4) . DNAJB4 serves asa multifunctional biomarker in pan-cancer, particularly in kidney neoplasm, and is closely related to tumorigenesis, staging, and prognosis. Targeting DNAJB4 could provide new therapeutic avenues for cancer treatment.  \nKeywords DNAJB4 · Pan-cancer · Kidney cancer · Bioinformatic analysis · Immunohistochemical staining · Biomarker  \nChuanmin Chu, Bingnan Lu, and Wenjia Fu have contributed equally to this work.  \n* Yifan Liu [lyf0501@sjtu.edu.cn](lyf0501@sjtu.edu.cn)  \n* Xiuwu Pan [panxiuwu@126.com](panxiuwu@126.com)  \n* Ming Chen [mingchenseu@126.com](mingchenseu@126.com)  \n1 Department of Urology, Zhongda Hospital Affiliated to Southeast University, Nanjing 210000, China  \n2 Department of Urology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200120, China  \n3 Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China  \nIntroduction  \nDNAJ proteins, also known as HSP40, are part of the heat shock protein family (HSPs) and function as molecular chaperones. They facilitate the transfer of substrates to HSP70 (DnaK), thereby activating its ATPase domain and supporting various biological processes, including protein folding, stress response, and the maintenance of proteostasis [1, 2] . Among the many HSP40 proteins, DnaJ homolog subfamily B member 4 (DNAJB4) has been shown to play a key role not only under stress conditions but also in normal cellular environments. Up to now, DNAJB4 is mainly reported to regulate protein homeostasis by identifying and managing misfolded substrates [2, 3] .  \nSeveral studies have highlighted the crucial involvement of DNAJB4 in tumor suppression. For example, DNAJB4 inhibits breast cancer cell growth, migration, and invasion [4, 5] . In non-small cell lung cancer (NSCLC), it reduces cell proliferation and promotes apoptosis, partly by inducing E-cadherin (Ecad) expression, thereby hindering  \ntumor progression [6–8] . Similarly, in gastric cancer cells, DNAJB4 acts as a sensor for structural defects in Ecad, distinguishing between normal a","cbCairElqPWFh6Z9","https://ap.wps.com/l/cbCairElqPWFh6Z9","pdf",15046222,"English","# Abstract\n## Introduction\n## Methods","[{\"question\":\"What is the main purpose of the study on DNAJB4?\",\"answer\":\"To perform an extensive pan-cancer analysis of DNAJB4 expression and determine its clinical value, with additional emphasis on kidney neoplasm using immunohistochemistry.\"},{\"question\":\"Which analytical components were used to assess DNAJB4 across cancers?\",\"answer\":\"The study integrates ceRNA analysis, protein-protein interaction networks, tumor purity estimation, genomic profiling, immune microenvironment evaluation, drug sensitivity assessment, and gene set enrichment analysis.\"},{\"question\":\"What did the study find about DNAJB4 expression in tumors versus normal tissues?\",\"answer\":\"DNAJB4 expression is significantly lower in tumor tissues than in normal tissues across the pan-cancer analysis.\"}]","Bioinformatic analysis and retrospective clinical study identifying DNAJB4 as a pan-cancer biomarker with a highlight on kidney cancer | PDF",1790190213,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/877cc356a48207b5e596409826cbee2c.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89008f5b06a270bfda773caad976e033.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9949ff2320d235c3eaae69b53e5c0a90.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5edb035d845b195d7c6b00d9400ecc88.webp",980,1301]